GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Edap TMS SA (NAS:EDAP) » Definitions » Institutional Ownership

Edap TMS (Edap TMS) Institutional Ownership : 6.42% (As of Apr. 30, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Edap TMS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Edap TMS's institutional ownership is 6.42%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Edap TMS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Edap TMS's Float Percentage Of Total Shares Outstanding is 76.79%.


Edap TMS Institutional Ownership Historical Data

The historical data trend for Edap TMS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edap TMS Institutional Ownership Chart

Edap TMS Historical Data

The historical data trend for Edap TMS can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 10.59 10.53 10.46 9.91 9.83 7.41 6.42 6.42 6.42 6.42

Edap TMS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Edap TMS (Edap TMS) Business Description

Traded in Other Exchanges
Address
Parc d'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.